CN113261592A - Probiotics goat milk powder and preparation method thereof - Google Patents
Probiotics goat milk powder and preparation method thereof Download PDFInfo
- Publication number
- CN113261592A CN113261592A CN202110614503.8A CN202110614503A CN113261592A CN 113261592 A CN113261592 A CN 113261592A CN 202110614503 A CN202110614503 A CN 202110614503A CN 113261592 A CN113261592 A CN 113261592A
- Authority
- CN
- China
- Prior art keywords
- powder
- goat milk
- probiotic
- freeze
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000843 powder Substances 0.000 title claims abstract description 140
- 239000006041 probiotic Substances 0.000 title claims abstract description 63
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 62
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 43
- 230000000529 probiotic effect Effects 0.000 claims abstract description 52
- 239000000203 mixture Substances 0.000 claims abstract description 42
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 22
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 17
- 235000010755 mineral Nutrition 0.000 claims abstract description 17
- 239000011707 mineral Substances 0.000 claims abstract description 17
- 235000015097 nutrients Nutrition 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 15
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 15
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 15
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 15
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 15
- 235000021119 whey protein Nutrition 0.000 claims abstract description 14
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 11
- QWJSAWXRUVVRLH-LREBCSMRSA-M 2-hydroxyethyl(trimethyl)azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound C[N+](C)(C)CCO.OC(=O)[C@H](O)[C@@H](O)C([O-])=O QWJSAWXRUVVRLH-LREBCSMRSA-M 0.000 claims abstract description 11
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 11
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 11
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 11
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000019483 Peanut oil Nutrition 0.000 claims abstract description 10
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 10
- 239000000312 peanut oil Substances 0.000 claims abstract description 10
- 239000008170 walnut oil Substances 0.000 claims abstract description 10
- 230000001863 plant nutrition Effects 0.000 claims abstract description 6
- 238000000855 fermentation Methods 0.000 claims description 67
- 230000004151 fermentation Effects 0.000 claims description 67
- 244000063299 Bacillus subtilis Species 0.000 claims description 58
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 238000002156 mixing Methods 0.000 claims description 48
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 46
- 239000008367 deionised water Substances 0.000 claims description 45
- 229910021641 deionized water Inorganic materials 0.000 claims description 45
- 239000001963 growth medium Substances 0.000 claims description 43
- 238000004108 freeze drying Methods 0.000 claims description 39
- 230000001580 bacterial effect Effects 0.000 claims description 36
- 239000010802 sludge Substances 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 29
- 239000000047 product Substances 0.000 claims description 29
- 230000001954 sterilising effect Effects 0.000 claims description 29
- 239000002609 medium Substances 0.000 claims description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 23
- 239000008103 glucose Substances 0.000 claims description 23
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 23
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 23
- 239000000839 emulsion Substances 0.000 claims description 22
- 238000011081 inoculation Methods 0.000 claims description 22
- 238000009630 liquid culture Methods 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 22
- 239000001888 Peptone Substances 0.000 claims description 19
- 108010080698 Peptones Proteins 0.000 claims description 19
- 238000012258 culturing Methods 0.000 claims description 19
- 235000019319 peptone Nutrition 0.000 claims description 19
- 239000003223 protective agent Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- 235000015278 beef Nutrition 0.000 claims description 16
- 230000001804 emulsifying effect Effects 0.000 claims description 16
- 235000020183 skimmed milk Nutrition 0.000 claims description 16
- 238000010298 pulverizing process Methods 0.000 claims description 15
- 229920001817 Agar Polymers 0.000 claims description 14
- 239000008272 agar Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 14
- 239000008176 lyophilized powder Substances 0.000 claims description 14
- 238000007873 sieving Methods 0.000 claims description 14
- 241000702462 Akkermansia muciniphila Species 0.000 claims description 12
- 238000007710 freezing Methods 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 230000004913 activation Effects 0.000 claims description 11
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 10
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 10
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 10
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 9
- 239000004473 Threonine Substances 0.000 claims description 9
- -1 citric acid diamine Chemical class 0.000 claims description 9
- 108010009004 proteose-peptone Proteins 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 8
- 229960005070 ascorbic acid Drugs 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 8
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 7
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 7
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 238000004945 emulsification Methods 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- 230000003068 static effect Effects 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 235000003130 Arctium lappa Nutrition 0.000 claims description 4
- 235000008078 Arctium minus Nutrition 0.000 claims description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 4
- 244000248825 Peltandra virginica Species 0.000 claims description 4
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 4
- 235000008599 Poria cocos Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 239000002211 L-ascorbic acid Substances 0.000 claims description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000011790 ferrous sulphate Substances 0.000 claims description 3
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000011607 retinol Substances 0.000 claims description 3
- 229960003471 retinol Drugs 0.000 claims description 3
- 235000020944 retinol Nutrition 0.000 claims description 3
- 239000011655 sodium selenate Substances 0.000 claims description 3
- 235000018716 sodium selenate Nutrition 0.000 claims description 3
- 229960001881 sodium selenate Drugs 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- 241000702460 Akkermansia Species 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 240000005528 Arctium lappa Species 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000007661 gastrointestinal function Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 36
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 20
- 244000179970 Monarda didyma Species 0.000 description 17
- 235000010672 Monarda didyma Nutrition 0.000 description 17
- 239000000706 filtrate Substances 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000001035 gastrointestinal tract Anatomy 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 11
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 229920001202 Inulin Polymers 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 230000007358 intestinal barrier function Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 6
- 229940029339 inulin Drugs 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 5
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000005027 intestinal barrier Anatomy 0.000 description 5
- 229940099596 manganese sulfate Drugs 0.000 description 5
- 239000011702 manganese sulphate Substances 0.000 description 5
- 235000007079 manganese sulphate Nutrition 0.000 description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 description 5
- 235000013923 monosodium glutamate Nutrition 0.000 description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229940073490 sodium glutamate Drugs 0.000 description 5
- 239000011781 sodium selenite Substances 0.000 description 5
- 235000015921 sodium selenite Nutrition 0.000 description 5
- 229960001471 sodium selenite Drugs 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 108010059820 Polygalacturonase Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 108010093305 exopolygalacturonase Proteins 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000208843 Arctium Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009291 secondary effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000020246 buffalo milk Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000003870 intestinal permeability Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2240/00—Use or particular additives or ingredients
- A23C2240/15—Use of plant extracts, including purified and isolated derivatives thereof, as ingredient in dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a probiotic goat milk powder and a preparation method thereof, wherein the probiotic goat milk powder comprises the following raw materials: goat milk, whey protein powder, peanut oil, walnut oil, plant nutrition powder, trehalose, L-carnitine, choline tartrate, compound vitamins, compound minerals, arachidonic acid, docosahexaenoic acid and a probiotic composition. The probiotic goat milk powder disclosed by the invention is rich and comprehensive in nutrition and good in taste, and can supplement nutrient elements for a human body in time, improve the gastrointestinal function of the human body and improve the immunity of the human body.
Description
Technical Field
The invention belongs to the technical field of food, and particularly relates to probiotic goat milk powder and a preparation method thereof.
Background
The milk powder is a mixed food made up by using fresh cow milk or goat milk as raw material through the processes of removing water content by adopting freezing or heating process, drying and adding nutrient supplementing components, such as vitamins and minerals, etc.. The goat milk is rich in protein, fat, vitamins, mineral substances and the like, has fat particles which are easy to absorb by human bodies, has high whey protein content and is not easy to cause allergy, is used as a main milk source which is parallel to the milk and the buffalo milk, and is a refined product in the dairy product. Chinese patent CN103651857A discloses an infant formula containing probiotics, its preparation method and its storage method, the infant formula containing probiotics comprises the following raw materials: raw milk, lactose, desalted whey powder, whey protein concentrate, structural grease, prebiotics, infant vitamin premix, infant mineral premix and active probiotic freeze-dried powder, wherein the viable count of the probiotics is stable, the storage time is long, the metabolic activity of total intestinal flora can be effectively stimulated, the immune system is improved, and the intestinal flora is balanced; but the content of the probiotics is not high, and the nutritional formula can be further optimized and improved.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides probiotic goat milk powder and a preparation method thereof.
In order to solve the technical problems, the invention adopts the technical scheme that:
the probiotic goat milk powder comprises the following raw materials: goat milk, whey protein powder, peanut oil, walnut oil, plant nutrition powder, trehalose, L-carnitine, choline tartrate, compound vitamins, compound minerals, arachidonic acid, docosahexaenoic acid and a probiotic composition.
The probiotic goat milk powder is prepared from the following raw materials in parts by weight: 400 parts of goat milk, 30-60 parts of whey protein powder, 1-3 parts of peanut oil, 1-2 parts of walnut oil, 3-5 parts of plant nutrient powder, 0.3-0.5 part of trehalose, 0.05-0.08 part of L-carnitine, 0.03-0.05 part of choline tartrate, 0.1-0.2 part of vitamin complex, 0.1-0.2 part of compound mineral, 0.1-0.3 part of arachidonic acid, 0.1-0.2 part of docosahexaenoic acid and 1-2 parts of probiotic composition.
The compound vitamin is a mixture of L-ascorbic acid, retinol, cholecalciferol, folic acid and D-calcium pantothenate according to the mass ratio of 5 (1-2): (0.5-1): (0.3-0.5): (0.3-0.5).
The compound mineral substance is a mixture of calcium chloride, ferrous sulfate, magnesium sulfate and sodium selenate according to a mass ratio of 15 (1-5) to (1-3) to (0.05-0.1).
The plant nutrition powder is a mixture of burdock powder, cassia seed powder and tuckahoe powder according to a mass ratio of (1-2) to (3).
The probiotic composition consists of 20-60 wt% of bacillus natto freeze-dried powder, 20-40 wt% of lactobacillus johnsonii freeze-dried powder and 20-40 wt% of akkermansia muciniphila freeze-dried powder. Preferably, the probiotic composition consists of 50 wt% of bacillus natto freeze-dried powder, 25 wt% of lactobacillus johnsonii freeze-dried powder and 25 wt% of akkermansia muciniphila freeze-dried powder.
B, bacillus natto: the bacillus natto has the effects of reducing and stabilizing blood sugar, can be applied to the preparation of medicines or preparations for reducing and stabilizing blood sugar, and has obvious effects of promoting the in vivo reduction of blood sugar and stabilizing blood sugar in intestinal expression; meanwhile, the bacillus natto has the functions of obviously losing weight, reducing the level of serum triglyceride, reducing the weight of white fat and reducing the diameter of fat cells; in addition, the bacillus natto enters the intestinal tract of an animal and survives for a long time, so that the immunity of the animal is enhanced for the growth and development of the animal, the number of dominant bacteria in the intestinal tract can be adjusted, the nutrient substances in the intestinal tract are changed, and the constipation is prevented.
Lactobacillus johnsonii: the lactobacillus johnsonii has the effects of improving obesity, reducing body fat and cholesterol, stabilizing intestinal bacteria phase, maintaining intestinal ecology with more bacteria and less bacteria, and further stimulating a mucosa to strengthen an immune system. The lactobacillus johnsonii can stimulate receptors on dendritic cells on the intestinal wall and combine, activate and activate transfer proteins in cells to move into nuclei to release a large amount of cytokines, promote secretion increase of leucocyte and interferon gamma, and inhibit immunoglobulin IgE by stimulating intestinal tract regulation immune response, so that an allergy phenomenon of excessive immune response is improved; meanwhile, the composition has good gastric acid and bile salt tolerance and cell adhesion, can colonize in the intestinal tract of a human body for more than 60 days, and also has good inhibition effect on pathogenic bacteria such as enterococcus faecalis, Escherichia coli, salmonella typhimurium and the like, thereby achieving the effects of cleaning and protecting the intestinal tract.
Akkermansia muciniphila: the akkermansia muciniphila has the function of improving the intestinal barrier. When the intestinal barrier is damaged, the intestinal permeability is increased, and pathogenic microorganisms, endotoxin and the like in the intestinal tract can enter blood or tissues through the intestinal barrier system, so that the body is in a disease state. Therefore, maintaining the intestinal barrier function normally plays a crucial role in the health status of the body. In addition, numerous studies have shown that the occurrence, development and outcome of many diseases (e.g., obesity, diabetes, pancreatitis, fatty liver, inflammatory bowel disease, cancer, etc.) are clinically closely related to intestinal barrier dysfunction. Therefore, intervention treatment for intestinal barrier dysfunction has a very positive effect on blocking disease progression and accelerating disease recovery.
The preparation method of the bacillus natto freeze-dried powder comprises the following steps:
s1, strain activation: marking out the bacillus natto on a solid culture medium A, and culturing for 18-30h at 32-40 ℃ to obtain activated bacillus natto; the preparation method of the solid culture medium A comprises the following steps: uniformly mixing 1-6 wt% of peptone, 1-4 wt% of glucose, 0.2-1 wt% of NaCl, 1-3 wt% of agar powder and the balance of deionized water, and sterilizing at the temperature of 110-;
s2, expanding culture: inoculating activated bacillus natto into a liquid culture medium A, wherein the inoculation amount is 1-5 wt%, and performing shake culture at 34-42 ℃ and 200-; the preparation method of the liquid culture medium A comprises the following steps: 6-14 wt% of skim milk powder, 1-4 wt% of organic inulin, 0.1-2 wt% of potassium dihydrogen phosphate, 0.0-1 wt% of magnesium sulfate and the balance of deionized water are uniformly mixed, 1-3mol/L of sodium carbonate is adopted to adjust the pH of the solution to be neutral, and the solution is sterilized for 10-30min at the temperature of 110-;
s3, fermentation: inoculating the seed liquid A into a fermentation medium A according to the inoculation amount of 2-8 wt%, and fermenting at 30-38 ℃ for 20-30h to obtain a fermentation product A; the preparation method of the fermentation medium A comprises the following steps: uniformly mixing 1-5 wt% of pea polypeptide, 1-4 wt% of lactose, 0.5-2 wt% of peptone, 0.1-1 wt% of dipotassium hydrogen phosphate, 0.05-1 wt% of manganese sulfate, 0.01-0.5 wt% of sodium selenite and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 1-3mol/L of sodium carbonate, and sterilizing at the temperature of 110-;
s4, collecting and emulsifying bacterial sludge: centrifuging the fermentation product A at 4000-7000rpm, discarding the supernatant, collecting bacterial sludge A, adding the bacterial sludge A into the freeze-drying protective agent A according to the mass ratio of 1 (1-4), and emulsifying at 100-300rpm for 15-40min to obtain an emulsion A; the lyoprotectant A is prepared as follows: uniformly mixing 2-8 wt% of glycerol, 10-30 wt% of skim milk powder, 2-6 wt% of ascorbic acid, 0.5-3 wt% of sodium glutamate, 0.5-2 wt% of prebiotics and the balance of deionized water;
s5, freeze-drying and crushing: freezing the emulsion A at-20-60 deg.C for 2-5h, and freezingDrying at vacuum temperature of-40-60 deg.C and vacuum degree of 0.1-0.5mbar for 10-30h, taking out, pulverizing, and sieving with 10-40 mesh sieve to obtain Bacillus natto lyophilized powder. Aiming at the defects of low viable count and difficult high-density fermentation of the common fermented bacillus natto, the lactobacillus johnsonii fermented by adopting the special fermentation medium and the fermentation method thereof has obviously improved thallus density compared with the common fermentation, and the viable count is not less than 2 multiplied by 1010cfu/g, which is difficult to achieve and overcome by the prior art, the viable count is greatly improved, and the high-density fermentation of the high viable bacillus natto is realized;
meanwhile, the bergamot extract is added as a nutrient of the bacillus natto, and active substances such as linalyl acetate, limonene, linalool, aldehydes, ketones, esters and the like which are main components of the bergamot extract can effectively promote the growth and the reproduction of the bacillus natto, and can inhibit the growth of mixed bacteria and improve the survival rate of the bacillus natto; in addition, the pea polypeptide is added into the fermentation medium, belongs to the active ingredient of the probiotic preparation of the bioactive peptide, and can play a role of a freeze-drying protective agent, so that the damage of freeze drying on the probiotic is prevented, the live bacteria survival rate of the bacillus natto is improved, the production period of the prepared bacillus natto is shortened, the production cost is reduced, and the production efficiency is improved.
Preferably, the preparation method of the bacillus natto freeze-dried powder comprises the following steps:
s1, strain activation: marking out the bacillus natto on a solid culture medium A, and culturing for 18-30h at 32-40 ℃ to obtain activated bacillus natto; the preparation method of the solid culture medium A comprises the following steps: uniformly mixing 1-6 wt% of peptone, 1-4 wt% of glucose, 0.2-1 wt% of NaCl, 1-3 wt% of agar powder and the balance of deionized water, and sterilizing at the temperature of 110-;
s2, expanding culture: inoculating activated bacillus natto into a liquid culture medium A, wherein the inoculation amount is 1-5 wt%, and performing shake culture at 34-42 ℃ and 200-; the preparation method of the liquid culture medium A comprises the following steps: 6-14 wt% of skim milk powder, 1-4 wt% of organic inulin, 0.1-2 wt% of potassium dihydrogen phosphate, 0.0-1 wt% of magnesium sulfate and the balance of deionized water are uniformly mixed, 1-3mol/L of sodium carbonate is adopted to adjust the pH of the solution to be neutral, and the solution is sterilized for 10-30min at the temperature of 110-;
s3, fermentation: inoculating the seed liquid A into a fermentation medium A according to the inoculation amount of 2-8 wt%, and fermenting at 30-38 ℃ for 20-30h to obtain a fermentation product A; the preparation method of the fermentation medium A comprises the following steps: 1-5 wt% of pea polypeptide, 1-4 wt% of lactose, 0.5-2 wt% of peptone, 0.1-1 wt% of dipotassium hydrogen phosphate, 0.05-1 wt% of manganese sulfate, 0.01-0.5 wt% of sodium selenite, 0.01-0.8 wt% of nutrient and the balance of deionized water are uniformly mixed, 1-3mol/L of sodium carbonate is adopted to adjust the pH of the solution to be neutral, and the solution is sterilized for 10-30min at the temperature of 110-;
s4, collecting and emulsifying bacterial sludge: centrifuging the fermentation product A at 4000-7000rpm, discarding the supernatant, collecting bacterial sludge A, adding the bacterial sludge A into the freeze-drying protective agent A according to the mass ratio of 1 (1-4), and emulsifying at 100-300rpm for 15-40min to obtain an emulsion A; the lyoprotectant A is prepared as follows: uniformly mixing 2-8 wt% of glycerol, 10-30 wt% of skim milk powder, 2-6 wt% of ascorbic acid, 0.5-3 wt% of sodium glutamate, 0.5-2 wt% of prebiotics and the balance of deionized water;
s5, freeze-drying and crushing: freezing the emulsion A at-20-60 ℃ for 2-5h, drying at-40-60 ℃ under vacuum degree of 0.1-0.5mbar for 10-30h, taking out, pulverizing, and sieving with 10-40 mesh sieve to obtain Bacillus natto lyophilized powder.
The nutritional agent in the S3 is a bergamot extract, and the preparation method of the bergamot extract comprises the following steps:
t1, cleaning, drying and crushing bergamot, sieving with a 30-70-mesh sieve, taking 50-100 parts by weight of bergamot powder, adding 800-1200 parts by weight of aqueous solution for mixing, adding 0.01-1 wt% of pectinase, adjusting the pH value to 3-5 by using 1-3mol/L hydrochloric acid, performing enzymolysis at constant temperature of 40-50 ℃ for 20-30min, continuously stirring at room temperature and 200-400rpm for 30-60min, and filtering to obtain filter residue A and filtrate A;
t2, taking all filter residues A of T1, adding 800-1200 parts by weight of 30-60 wt% ethanol aqueous solution for mixing, placing the mixture at 40-60 ℃, ultrasonic power of 300-500W and ultrasonic frequency of 30-60kHz for ultrasonic 0.5-2h, filtering to obtain filtrate B, combining the filtrate A and the filtrate B, and reducing the concentration to 1/10-1/20 of the original volume at 80 ℃ to obtain concentrated solution;
t3, vacuum drying the concentrated solution of T2 at 70-90 deg.C to constant weight to obtain fructus Citri Sarcodactylis extract.
The prebiotics in the S4 are any one of isomaltooligosaccharide, fructo-oligosaccharide, malto-oligosaccharide, raffinose and isomerized lactose.
The preparation method of the lactobacillus johnsonii freeze-dried powder comprises the following steps:
w1, strain activation: taking Lactobacillus johnsonii to streak on a solid culture medium B, and statically culturing for 30-48h at the constant temperature of 30-45 ℃ to obtain activated Lactobacillus johnsonii; the solid medium B was prepared as follows: uniformly mixing 1-5 wt% of peptone, 1-4 wt% of glucose, 0.1-1 wt% of magnesium sulfate, 1-5 wt% of agar powder and the balance of deionized water, and sterilizing at the temperature of 110-;
w2, expanding culture: inoculating activated Lactobacillus johnsonii in a liquid culture medium B, wherein the inoculation amount is 1-5 wt%, and culturing in a shaking table at 32-40 ℃ for 18-36h to obtain a seed solution B; the preparation method of the liquid culture medium B comprises the following steps: the beef extract is 10-20 wt%, the peptone is 10-30 wt%, the glucose is 20-40 wt%, the sodium acetate is 2-8 wt%, the citric acid diamine is 0.5-2 wt%, the dipotassium phosphate is 0.1-1 wt%, the Tween-800.1-1 wt%, the magnesium sulfate is 0.1-0.5 wt%, and the balance is deionized water, and the beef extract is uniformly mixed and sterilized at the temperature of 110-;
w3, fermentation: inoculating the seed liquid B into a fermentation medium B according to the inoculation amount of 2-6 wt%, and performing static fermentation at 30-45 ℃ for 8-18h to obtain a fermentation product B; the preparation method of the fermentation medium B comprises the following steps: the beef extract is 10-20 wt%, the peptone is 10-30 wt%, the glucose is 20-40 wt%, the sodium acetate is 2-8 wt%, the citric acid diamine is 0.5-2 wt%, the dipotassium phosphate is 0.1-1 wt%, the Tween-800.1-1 wt%, the magnesium sulfate is 0.1-0.5 wt%, and the balance is deionized water, and the beef extract is uniformly mixed and sterilized at the temperature of 110-;
w4, bacterial sludge collection and emulsification: centrifuging the fermentation product B at 10000-15000rpm for 10-30min, removing the supernatant, collecting bacterial sludge B, adding the bacterial sludge B into the freeze-drying protective agent B according to the mass ratio of 1 (1-4), and emulsifying at 150-200rpm for 10-30min to obtain an emulsion B; the preparation method of the freeze-drying protective agent B comprises the following steps: uniformly mixing 10-30 wt% of skimmed milk powder, 2-8 wt% of trehalose, 3-8 wt% of glycerol, 1-4 wt% of maltodextrin and the balance of deionized water;
w5, lyophilization and pulverization: freezing the emulsion B at-40 to-50 ℃ for 2-8h, drying at-50 to-70 ℃ under vacuum at 0.1 to 0.5mbar for 40-60h, taking out, pulverizing, and sieving with 10-40 mesh sieve to obtain Lactobacillus johnsonii lyophilized powder.
The preparation method of the akkermansia muciniphila freeze-dried powder comprises the following steps:
x1, strain activation: taking Ackermanella muciniphila to streak on a solid culture medium C, and culturing for 20-28h at the constant temperature of 35-40 ℃ to obtain activated Ackermanella muciniphila; the solid medium C was prepared as follows: uniformly mixing 1-5 wt% of casein peptone, 0.5-2 wt% of glucose, 0.5-2 wt% of fucose, 0.1-1 wt% of threonine, 1-5 wt% of agar powder and the balance of deionized water, adjusting the pH to 6.0-7.0 by using 1-3mol/L hydrochloric acid solution, and sterilizing at the temperature of 110-;
x2, expanding culture: inoculating Ackermanella muciniphila in a liquid culture medium C with the inoculation amount of 1-4 wt%, and culturing in a shaker at 35-40 deg.C for 20-28h to obtain a seed solution C; the preparation method of the liquid culture medium C comprises the following steps: uniformly mixing 10-30 wt% of beef extract, 1-5 wt% of casein peptone, 0.5-2 wt% of glucose, 0.5-2 wt% of fucose, 0.1-0.5 wt% of threonine, 0.1-0.5 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH to 6.0-7.0 by using 1-3mol/L hydrochloric acid solution, and sterilizing at the temperature of 110-;
x3, fermentation: inoculating the seed liquid C into a fermentation culture medium C according to the inoculation amount of 2-8 wt%, and performing static fermentation at 35-40 ℃ for 12-24h to obtain a fermentation product C; the preparation method of the fermentation medium C comprises the following steps: uniformly mixing 10-30 wt% of beef extract, 1-5 wt% of casein peptone, 0.5-2 wt% of glucose, 0.5-2 wt% of fucose, 0.1-0.5 wt% of threonine, 0.1-0.5 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH to 6.0-7.0 by using 1-3mol/L hydrochloric acid solution, and sterilizing at the temperature of 110-;
x4, bacterial sludge collection and emulsification: placing the fermentation product B obtained in the step X3 at 6000-10000rpm for centrifugation for 10-30min, removing the supernatant, collecting bacterial sludge C, adding the bacterial sludge C into the freeze-drying protective agent C according to the mass ratio of 1 (1-4), and emulsifying at 100-300rpm for 10-30min to obtain an emulsion C; the preparation method of the freeze-drying protective agent C comprises the following steps: uniformly mixing 10-30 wt% of skimmed milk powder, 2-8 wt% of glycerol, 3-10 wt% of oligomeric maltose and the balance of deionized water;
x5, lyophilization and pulverization: freezing the emulsion C at-40 to-50 ℃ for 2-8h, drying at-50 to-70 ℃ under a vacuum degree of 0.1 to 0.5mbar for 40-60h, taking out of the bin, crushing, and sieving with a 10-40 mesh sieve to obtain the adhesive protein akkermansia freeze-dried powder.
The preparation method of the probiotic goat milk powder comprises the following steps:
adding whey protein powder, peanut oil, walnut oil, plant nutrient powder, trehalose, L-carnitine, choline tartrate, compound vitamins and compound minerals into goat milk, and uniformly mixing to obtain a mixed material I; preheating the mixed material I to 50-70 ℃, homogenizing at the homogenizing pressure of 200-220bar, heating to 90-100 ℃, and preserving the heat for 3-8s for sterilization to obtain a mixed material II; carrying out triple effect concentration on the mixed material II to 40-50% of the original weight to obtain a mixed material III; spray drying the mixture III, and cooling to room temperature to obtain a mixture IV; adding arachidonic acid, docosahexaenoic acid and a probiotic composition into the mixed material IV and uniformly mixing; and packaging, detecting and warehousing to obtain the product.
The first-effect pressure of the triple-effect concentration is 300-320bar, and the first-effect temperature is 70-75 ℃; the secondary effect pressure is 250-260bar, and the secondary effect temperature is 65-68 ℃; the triple effect temperature is 60-63 ℃; wherein the air inlet temperature of the spray drying is 185-190 ℃, the air outlet temperature is 90-95 ℃, and the air flow rate is 0.2-0.3m3/min。
The invention has the beneficial effects that: the probiotic goat milk powder disclosed by the invention is rich and comprehensive in nutrition and good in taste, and can supplement nutrient elements for a human body in time, improve the gastrointestinal tract function of the human body and improve the immunity of the human body. The composite probiotic composition consists of bacillus natto freeze-dried powder, lactobacillus johnsonii freeze-dried powder and akkermansia muciniphila freeze-dried powder, growth and reproduction of beneficial bacteria in intestinal tracts and intestinal health are facilitated, and the three components synergistically play a role in protecting the intestinal tracts, improving the microbial balance of the intestinal tracts, regulating the intestinal tract function and improving the immunity of organisms.
Detailed Description
The above summary of the present invention is described in further detail below with reference to specific embodiments, but it should not be understood that the scope of the above subject matter of the present invention is limited to the following examples.
Introduction of some raw materials in this application:
goat milk, which is adopted as goat milk, is standardized, subjected to impurity separation and acceptance, pasteurized and homogenized.
The preparation method of the lactobacillus johnsonii freeze-dried powder comprises the following steps:
w1, strain activation: taking Lactobacillus johnsonii to streak on a solid culture medium B, and statically culturing for 36h at the constant temperature of 38 ℃ to obtain activated Lactobacillus johnsonii; the solid medium B was prepared as follows: uniformly mixing 3 wt% of peptone, 2 wt% of glucose, 0.5 wt% of magnesium sulfate, 2 wt% of agar powder and the balance of deionized water, and sterilizing at 120 ℃ for 20 min;
w2, expanding culture: inoculating activated lactobacillus johnsonii into a liquid culture medium B, wherein the inoculation amount is 2 wt%, and culturing in a shaking table at 36 ℃ for 24 hours to obtain a seed solution B; the preparation method of the liquid culture medium B comprises the following steps: uniformly mixing 15 wt% of beef extract, 15 wt% of peptone, 30 wt% of glucose, 5 wt% of sodium acetate, 1 wt% of diamine citrate, 0.5 wt% of dipotassium phosphate, 0.2 wt% of tween-800.5, 0.2 wt% of magnesium sulfate and the balance of deionized water, and sterilizing at 120 ℃ for 20 min;
w3, fermentation: inoculating the seed liquid B into a fermentation medium B according to the inoculation amount of 4 wt%, and performing static fermentation for 10h at 36 ℃ to obtain a fermentation product B; the preparation method of the fermentation medium B comprises the following steps: 15 wt% of beef extract, 15 wt% of peptone, 30 wt% of glucose, 5 wt% of sodium acetate, 1 wt% of diamine citrate, 0.5 wt% of dipotassium phosphate, 0.2 wt% of tween-800.5 and 0.2 wt% of magnesium sulfate, and sterilizing at 120 ℃ for 20 min;
w4, bacterial sludge collection and emulsification: centrifuging the fermentation product B at 12000rpm for 15min, removing supernatant, collecting bacterial sludge B, adding the bacterial sludge B into the freeze-drying protective agent B according to the mass ratio of 1:2, and emulsifying at 180rpm for 15min to obtain an emulsion B; the preparation method of the freeze-drying protective agent B comprises the following steps: uniformly mixing 20 wt% of skimmed milk powder, 5 wt% of trehalose, 5 wt% of glycerol, 2 wt% of maltodextrin and the balance of deionized water;
w5, lyophilization and pulverization: freezing the emulsion B at-45 deg.C for 3h, drying at-60 deg.C under vacuum degree of 0.2mbar for 48h, taking out, pulverizing, and sieving with 20 mesh sieve to obtain Lactobacillus johnsonii lyophilized powder.
Lactobacillus johnsonii, deposited in China center for type culture Collection with a collection number of CCTCC NO: m20191013.
The preparation method of the akkermansia muciniphila freeze-dried powder comprises the following steps:
x1, strain activation: taking Ackermanella muciniphila to streak on a solid culture medium C, and culturing for 24h at the constant temperature of 37 ℃ to obtain activated Ackermanella muciniphila; the solid medium C was prepared as follows: uniformly mixing 3 wt% of casein peptone, 1 wt% of glucose, 1 wt% of fucose, 0.2 wt% of threonine, 3 wt% of agar powder and the balance of deionized water, adjusting the pH to 6.5 by using 2mol/L hydrochloric acid, and sterilizing at 120 ℃ for 20 min;
x2, expanding culture: inoculating the activated akkermansia muciniphila in a liquid culture medium C, wherein the inoculation amount is 2 wt%, and culturing in a shaker at 37 ℃ for 24h to obtain a seed solution C; the preparation method of the liquid culture medium C comprises the following steps: uniformly mixing 15 wt% of beef extract, 3 wt% of casein peptone, 1 wt% of glucose, 1 wt% of fucose, 0.2 wt% of threonine, 0.2 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH to 6.5 by using 2mol/L hydrochloric acid, and sterilizing at 120 ℃ for 20 min;
x3, fermentation: inoculating the seed solution C into a fermentation medium C according to the inoculation amount of 4 wt%, and performing static fermentation at 37 ℃ for 18h to obtain a fermentation product C; the preparation method of the fermentation medium C comprises the following steps: uniformly mixing 15 wt% of beef extract, 3 wt% of casein peptone, 1 wt% of glucose, 1 wt% of fucose, 0.2 wt% of threonine, 0.2 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH to 6.5 by using 2mol/L hydrochloric acid, and sterilizing at 120 ℃ for 20 min;
x4, bacterial sludge collection and emulsification: placing the fermentation product B obtained in the step X3 at 8000rpm, centrifuging for 20min, removing supernatant, collecting bacterial sludge C, adding the bacterial sludge C into the freeze-drying protective agent C according to the mass ratio of 1:2, and emulsifying at 200rpm for 15min to obtain emulsion C; the preparation method of the freeze-drying protective agent C comprises the following steps: uniformly mixing 20 wt% of skimmed milk powder, 5 wt% of glycerol, 5 wt% of oligomeric maltose and the balance of deionized water;
x5, lyophilization and pulverization: freezing the emulsion C at-45 deg.C for 3h, drying at-60 deg.C under vacuum degree of 0.2mbar for 48h, taking out, pulverizing, and sieving with 20 mesh sieve to obtain the lyophilized powder of Acermanniella muciniphila.
Akkermansia muciniphila, purchased from the china industrial microbial strain collection management center, under the strain collection number: CICC 24917.
Bacillus natto, Bacillus subtilis, is preserved in China general microbiological culture Collection center, and the preservation number is: CGMCC No. 5769.
Defatted milk powder and whey protein powder are purchased from Zhengzhou Bai Si Te food additive Co., Ltd, and are in food grade.
Organic inulin is purchased from food science and technology limited, mingjie, henna, in an amount of: 99 percent and is in food grade.
The pea polypeptide is purchased from Gansu Probiotics and auspicious biotechnology limited, the total protein is more than or equal to 90 percent, the peptide content is more than or equal to 80 percent, the molecular weight is less than 1000, and the pea polypeptide is in food grade.
Bergamot, burdock powder, cassia seed powder and tuckahoe powder are purchased in the Bozhou city and are measured by the cooperative society of the Xianggang Chinese medicinal plant planting specialty in urban areas.
Fucose and trehalose are purchased from Zhengzhou Bai Si Te food additive Co Ltd, and are in food grade.
Pectinase was purchased from huizhou yuan biotechnology ltd, enzyme activity: 10 ten thousand U/g and food grade.
Isomaltooligosaccharides were purchased from seian university harvest biotechnology limited, type: IMO-500, Cat number: 45000, content of active substance: 99 percent and is in food grade.
Example 1
The probiotic goat milk powder is prepared from the following raw materials: 400 parts of goat milk, 60 parts of whey protein powder, 3 parts of peanut oil, 2 parts of walnut oil, 5 parts of plant nutrient powder, 0.5 part of trehalose, 0.06 part of L-carnitine, 0.05 part of choline tartrate, 0.2 part of vitamin complex, 0.2 part of compound mineral, 0.3 part of arachidonic acid, 0.2 part of docosahexaenoic acid and 2 parts of probiotic composition.
The preparation method of the probiotic goat milk powder comprises the following steps:
adding whey protein powder, peanut oil, walnut oil, plant nutrient powder, trehalose, L-carnitine, choline tartrate, compound vitamins and compound mineral substances into goat milk according to a formula, and uniformly mixing to obtain a mixed material I; preheating the mixed material I to 60 ℃, homogenizing under the homogenizing pressure of 210bar, heating to 95 ℃, preserving heat for 5s, and sterilizing to obtain a mixed material II; carrying out triple effect concentration on the mixed material II to 48% of the original weight to obtain a mixed material III; wherein the first effect pressure of the triple effect concentration is 310bar, and the first effect temperature is 72 ℃; the double-effect pressure is 250bar, and the double-effect temperature is 66 ℃; the triple effect temperature is 62 ℃; spray drying the mixture III, and cooling to room temperature to obtain a mixture IV; wherein the air inlet temperature of spray drying is 188 ℃, the air outlet temperature is 92 ℃, and the air flow rate is 0.23m3Min; adding arachidonic acid, docosahexaenoic acid and a probiotic composition into the mixed material IV and uniformly mixing; and packaging, detecting and warehousing to obtain the product.
The compound vitamin is a mixture of L-ascorbic acid, retinol, cholecalciferol, folic acid and D-calcium pantothenate according to a mass ratio of 5:2:1:0.5: 0.5; the compound mineral is a mixture of calcium chloride, ferrous sulfate, magnesium sulfate and sodium selenate according to a mass ratio of 15:5:3: 0.06; the plant nutrition powder is a mixture of burdock powder, cassia seed powder and tuckahoe powder according to a mass ratio of 1:1: 3.
The probiotic composition is bacillus natto freeze-dried powder; the preparation method of the bacillus natto freeze-dried powder comprises the following steps:
s1, strain activation: marking out the bacillus natto on a solid culture medium A, and culturing for 24 hours at 37 ℃ to obtain activated bacillus natto; the preparation method of the solid culture medium A comprises the following steps: uniformly mixing 3 wt% of peptone, 2 wt% of glucose, 0.5 wt% of NaCl, 2 wt% of agar powder and the balance of deionized water, and sterilizing at 120 ℃ for 20 min;
s2, expanding culture: inoculating activated bacillus natto into a liquid culture medium A, wherein the inoculation amount is 2 wt%, and performing shaking culture at 38 ℃ and 300rpm for 12 hours to obtain a seed solution A; the preparation method of the liquid culture medium A comprises the following steps: uniformly mixing 10 wt% of skim milk powder, 2 wt% of organic inulin, 1 wt% of potassium dihydrogen phosphate, 0.2 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 2mol/L sodium carbonate, and sterilizing at 120 ℃ for 20 min;
s3, fermentation: inoculating the seed liquid A into a fermentation medium A according to the inoculation amount of 5 wt%, and fermenting at 35 ℃ for 24h to obtain a fermentation product A; the preparation method of the fermentation medium A comprises the following steps: uniformly mixing 2 wt% of pea polypeptide, 2 wt% of lactose, 1 wt% of peptone, 0.2 wt% of dipotassium hydrogen phosphate, 0.1 wt% of manganese sulfate, 0.05 wt% of sodium selenite, 0.1 wt% of a nutrient and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 2mol/L sodium carbonate, and sterilizing at 120 ℃ for 20 min;
s4, collecting and emulsifying bacterial sludge: centrifuging the fermentation product A at 5000rpm for 15min, removing supernatant, collecting bacterial sludge A, adding the bacterial sludge A into the freeze-drying protective agent A according to the mass ratio of 1:2, and emulsifying at 200rpm for 30min to obtain an emulsion A; the lyoprotectant A is prepared as follows: uniformly mixing 5 wt% of glycerol, 20 wt% of skim milk powder, 4 wt% of ascorbic acid, 1.5 wt% of sodium glutamate, 1 wt% of isomaltooligosaccharide and the balance of deionized water;
s5, freeze-drying and crushing: freezing the emulsion A at-40 deg.C for 3h, drying at-50 deg.C under vacuum degree of 0.2mbar for 20h, taking out, pulverizing, and sieving with 20 mesh sieve to obtain Bacillus natto lyophilized powder.
The nutritional agent is a bergamot extract, and the preparation method of the bergamot extract comprises the following steps:
t1, cleaning, drying and crushing bergamot, sieving with a 50-mesh sieve, taking 80 parts by weight of bergamot powder, adding 1000 parts by weight of deionized water solution for mixing, adding 0.1 wt% of pectinase, adjusting pH to 4 by using 2mol/L hydrochloric acid, carrying out enzymolysis at a constant temperature of 45 ℃ for 25min, continuously stirring at room temperature and 300rpm for 40min, and filtering to obtain filter residue A and filtrate A;
t2, taking all filter residues A of T1, adding 1000 parts by weight of 40 wt% ethanol aqueous solution, mixing, putting into ultrasonic waves with the ultrasonic power of 400W and the ultrasonic frequency of 45kHz at 50 ℃ for 1h, filtering to obtain filtrate B, combining the filtrate A and the filtrate B, and reducing and concentrating the filtrate A and the filtrate B to 1/15 of the original volume at 80 ℃ to obtain concentrated solution;
t3, vacuum drying the concentrated solution of T2 at 80 deg.C to constant weight to obtain fructus Citri Sarcodactylis extract.
Example 2
Essentially the same as example 1, except that: the probiotic composition consists of 50 wt% of bacillus natto freeze-dried powder and 50 wt% of lactobacillus johnsonii freeze-dried powder. The preparation method of the bacillus natto freeze-dried powder is the same as that of the example 1.
Example 3
Essentially the same as example 1, except that: the probiotic composition consists of 50 wt% of bacillus natto freeze-dried powder and 50 wt% of akmansia muciniphila freeze-dried powder. The preparation method of the bacillus natto freeze-dried powder is the same as that of the example 1.
Example 4
Essentially the same as example 1, except that: the probiotic composition consists of 50 wt% of bacillus natto freeze-dried powder, 25 wt% of lactobacillus johnsonii freeze-dried powder and 25 wt% of akkermansia muciniphila freeze-dried powder. The preparation method of the bacillus natto freeze-dried powder is the same as that of the example 1. Wherein the viable count of Bacillus natto lyophilized powder is 3.7 × 1011cfu/g, viable count in Lactobacillus johnsonii freeze-dried powder 8.3 x 1011cfu/g, viable count in Ackermanella mucronata freeze-dried powder 2.0 x 1011cfu/g。
Example 5
Essentially the same as example 1, except that: the preparation method of the bacillus natto freeze-dried powder comprises the following steps:
s1, strain activation: marking out the bacillus natto on a solid culture medium A, and culturing for 24 hours at 37 ℃ to obtain activated bacillus natto; the preparation method of the solid culture medium A comprises the following steps: uniformly mixing 3 wt% of peptone, 2 wt% of glucose, 0.5 wt% of NaCl, 2 wt% of agar powder and the balance of deionized water, and sterilizing at 120 ℃ for 20 min;
s2, expanding culture: inoculating activated bacillus natto into a liquid culture medium A, wherein the inoculation amount is 2 wt%, and performing shaking culture at 38 ℃ and 300rpm for 12 hours to obtain a seed solution A; the preparation method of the liquid culture medium A comprises the following steps: uniformly mixing 10 wt% of skim milk powder, 2 wt% of organic inulin, 1 wt% of potassium dihydrogen phosphate, 0.2 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 2mol/L sodium carbonate, and sterilizing at 120 ℃ for 20 min;
s3, fermentation: inoculating the seed liquid A into a fermentation medium A according to the inoculation amount of 5 wt%, and fermenting at 35 ℃ for 24h to obtain a fermentation product A; the preparation method of the fermentation medium A comprises the following steps: uniformly mixing 2 wt% of pea polypeptide, 2 wt% of lactose, 1 wt% of peptone, 0.2 wt% of dipotassium hydrogen phosphate, 0.1 wt% of manganese sulfate, 0.05 wt% of sodium selenite and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 2mol/L sodium carbonate, and sterilizing at 120 ℃ for 20 min;
s4, collecting and emulsifying bacterial sludge: centrifuging the fermentation product A at 5000rpm for 15min, removing supernatant, collecting bacterial sludge A, adding the bacterial sludge A into the freeze-drying protective agent A according to the mass ratio of 1:2, and emulsifying at 200rpm for 30min to obtain an emulsion A; the lyoprotectant A is prepared as follows: uniformly mixing 5 wt% of glycerol, 20 wt% of skim milk powder, 4 wt% of ascorbic acid, 1.5 wt% of sodium glutamate, 1 wt% of isomaltooligosaccharide and the balance of deionized water;
s5, freeze-drying and crushing: freezing the emulsion A at-40 deg.C for 3h, drying at-50 deg.C under vacuum degree of 0.2mbar for 20h, taking out, pulverizing, and sieving with 20 mesh sieve to obtain Bacillus natto lyophilized powder.
Example 6
Essentially the same as example 1, except that: the preparation method of the bacillus natto freeze-dried powder comprises the following steps:
s1, strain activation: marking out the bacillus natto on a solid culture medium A, and culturing for 24 hours at 37 ℃ to obtain activated bacillus natto; the preparation method of the solid culture medium A comprises the following steps: uniformly mixing 3 wt% of peptone, 2 wt% of glucose, 0.5 wt% of NaCl, 2 wt% of agar powder and the balance of deionized water, and sterilizing at 120 ℃ for 20 min;
s2, expanding culture: inoculating activated bacillus natto into a liquid culture medium A, wherein the inoculation amount is 2 wt%, and performing shaking culture at 38 ℃ and 300rpm for 12 hours to obtain a seed solution A; the preparation method of the liquid culture medium A comprises the following steps: uniformly mixing 10 wt% of skim milk powder, 2 wt% of organic inulin, 1 wt% of potassium dihydrogen phosphate, 0.2 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 2mol/L sodium carbonate, and sterilizing at 120 ℃ for 20 min;
s3, fermentation: inoculating the seed liquid A into a fermentation medium A according to the inoculation amount of 5 wt%, and fermenting at 35 ℃ for 24h to obtain a fermentation product A; the preparation method of the fermentation medium A comprises the following steps: uniformly mixing 2 wt% of lactose, 1 wt% of peptone, 0.2 wt% of dipotassium phosphate, 0.1 wt% of manganese sulfate, 0.05 wt% of sodium selenite, 0.1 wt% of nutrient and the balance of deionized water, adjusting the pH of the solution to be neutral by adopting 2mol/L sodium carbonate, and sterilizing at 120 ℃ for 20 min;
s4, collecting and emulsifying bacterial sludge: centrifuging the fermentation product A at 5000rpm for 15min, removing supernatant, collecting bacterial sludge A, adding the bacterial sludge A into the freeze-drying protective agent A according to the mass ratio of 1:2, and emulsifying at 200rpm for 30min to obtain an emulsion A; the lyoprotectant A is prepared as follows: uniformly mixing 5 wt% of glycerol, 20 wt% of skim milk powder, 4 wt% of ascorbic acid, 1.5 wt% of sodium glutamate, 1 wt% of isomaltooligosaccharide and the balance of deionized water;
s5, freeze-drying and crushing: freezing the emulsion A at-40 deg.C for 3h, drying at-50 deg.C under vacuum degree of 0.2mbar for 20h, taking out, pulverizing, and sieving with 20 mesh sieve to obtain Bacillus natto lyophilized powder.
The nutritional agent is a bergamot extract, and the preparation method of the bergamot extract comprises the following steps:
t1, cleaning, drying and crushing bergamot, sieving with a 50-mesh sieve, taking 80 parts by weight of bergamot powder, adding 1000 parts by weight of deionized water solution for mixing, adding 0.1 wt% of pectinase, adjusting pH to 4 by using 2mol/L hydrochloric acid, carrying out enzymolysis at a constant temperature of 45 ℃ for 25min, continuously stirring at room temperature and 300rpm for 40min, and filtering to obtain filter residue A and filtrate A;
t2, taking all filter residues A of T1, adding 1000 parts by weight of 40 wt% ethanol aqueous solution, mixing, putting into ultrasonic waves with the ultrasonic power of 400W and the ultrasonic frequency of 45kHz at 50 ℃ for 1h, filtering to obtain filtrate B, combining the filtrate A and the filtrate B, and reducing and concentrating the filtrate A and the filtrate B to 1/15 of the original volume at 80 ℃ to obtain concentrated solution;
t3, vacuum drying the concentrated solution of T2 at 80 deg.C to constant weight to obtain fructus Citri Sarcodactylis extract.
Comparative example 1
Essentially the same as example 4, except that: the probiotic goat milk powder is prepared from the following raw materials: 400 parts of goat milk, 60 parts of whey protein powder, 3 parts of peanut oil, 2 parts of walnut oil, 0.5 part of trehalose, 0.06 part of L-carnitine, 0.05 part of choline tartrate, 0.2 part of vitamin complex, 0.2 part of compound mineral, 0.3 part of arachidonic acid, 0.2 part of docosahexaenoic acid and 2 parts of probiotic composition.
Comparative example 2
Essentially the same as example 4, except that: the probiotic goat milk powder is prepared from the following raw materials: 400 parts of goat milk, 60 parts of whey protein powder, 5 parts of plant nutrient powder, 0.5 part of trehalose, 0.06 part of L-carnitine, 0.05 part of choline tartrate, 0.2 part of compound vitamin, 0.2 part of compound mineral, 0.3 part of arachidonic acid, 0.2 part of docosahexaenoic acid and 2 parts of probiotic composition.
Test example 1
And (3) evaluating the functions of the probiotic goat milk powder: 60 SPF-grade Wistar rats of 14d birth were selected and randomly divided into 3 groups of 10 males and females in each group. The probiotics goat milk powder (prepared by warm boiled water at 37 ℃ to be 1g/100mL) of the example 4 and the comparative examples 1-2 is respectively fed, and the goat milk powder is freely drunk for 7 days. After the test, the number of stools in the mouse 1d was observed, and the change in body weight before and after the test was counted.
TABLE 1 functional evaluation results of probiotic goat milk powder
Weight gain g | Stool frequency, times/d | |
Example 4 | 10.2 | 1.8 |
Comparative example 1 | 8.8 | 1.3 |
Comparative example 2 | 9.5 | 1.5 |
Test example 2
And (3) measuring the viable count before freeze-drying: the Bacillus natto bacterial sludge, the Lactobacillus johnsonii bacterial sludge and the Ackermansia muciniphila bacterial sludge collected in the above examples 1 and 5-6 are taken and put into 10ml of 0.85% (m/v) physiological saline to be shaken evenly, and the viable count is measured by a gradient dilution method and an agar culture medium.
Fully shaking the cultured bacteria liquid on a clean bench, and continuously diluting all samples by 10 times with the dilution degree of 10-1、10-2、10-3、10-4、10-5、10-6And 10-7. Selecting appropriate dilution, uniformly inoculating 1mL of the dilution into a modified MRS agar culture medium which is sterilized, cooled to about 45 ℃, shaking uniformly, culturing at 37 ℃ for 48h, selecting the dilution with about 100 colony counts, selecting 2 dilutions for each sample, performing 3 repeated averaging on each dilution, and calculating the unit viable count (cfu/g).
And (3) measuring the viable count after freeze-drying: taking 1g of Bacillus natto freeze-dried powder, Lactobacillus johnsonii freeze-dried powder and Ackermannheimia muciniphila freeze-dried powder, adding 10mL of 0.85% (m/v) physiological saline into a centrifugal tube for restoration, fully oscillating until the freeze-dried powder is completely dissolved, and respectively diluting with 10 degrees of dilution-1、10-2、10-3、10-4、10-5、10-6And 10-7. Selecting appropriate dilution, uniformly inoculating 1mL of the diluted solution into a modified MRS agar culture medium which is sterilized and then cooled to about 45 ℃, shaking uniformly, and culturing at 37 ℃ for 48h, wherein the dilution with about 100 colonies is selected.
TABLE 2 detection results of viable count before lyophilization
Bacillus natto (cfu/g) | |
Example 1 | 9.8×1011 |
Example 5 | 4.1×1010 |
Example 6 | 6.8×1010 |
TABLE 3 detection results of viable count after lyophilization
Bacillus natto (cfu/g) | |
Example 1 | 3.7×1011 |
Example 5 | 1.4×1010 |
Example 6 | 2.8×1010 |
From the results, the content of the viable count can be effectively improved by adding the bergamot extract serving as a nutrient in the preparation process of the bacillus natto, the content of the viable count can also be improved to a certain extent by adding the pea polypeptide, and the viable count is also effectively improved after freeze-drying. The reason is that the main components of the bergamot extract, such as linalyl acetate, limonene, linalool, aldehydes, ketones, esters and other active substances, can effectively promote the growth and the propagation of the bacillus natto, and can inhibit the growth of mixed bacteria and improve the survival rate of the bacillus natto; in addition, the pea polypeptide belongs to the effective component of the probiotic preparation of the bioactive peptide, and simultaneously can play the role of a freeze-drying protective agent, so that the damage of freeze-drying to probiotics is prevented, the survival rate of viable bacteria of bacillus natto is improved, the defatted milk powder in the freeze-dried powder can prevent the cell damage by stabilizing the composition of cell membranes, the defatted milk powder also contains protein and can provide a protective layer for the cells, in addition, a porous structure is generated in the freeze-drying process, so that the dehydration is easier, the survival rate of thalli can be improved, the excessive moisture of the product is removed by freeze-drying, and the stability of the finished product is improved; meanwhile, the pea polypeptide and the probiotics are freeze-dried together, so that the activity of the probiotics is kept, the effective viable count of the finished product is higher, and the activity of the pea polypeptide can be improved. Meanwhile, the probiotic composition prepared by the invention has a production period, so that the production cost is reduced and the production efficiency is improved.
Test example 3
Rat testing: SPF-class Wistar rats weighing 150 + -20 g were selected and randomly divided into experimental groups (examples 1-6) of 10 males and females per group. The rats are numbered before the test, the probiotic composition in the example 1-6 is prepared into a probiotic composition solution with the concentration of 100mg/L by warm boiled water at 37 ℃, the probiotic composition solution in the example 1-6 is perfused for 3 times a day by an experimental group of rats with the dosage of 0.5mL each time, warm boiled water at 37 ℃ is perfused for 3 times a day by a blank group of rats, the rats in the experimental group and the blank group freely eat and drink water and are continuously fed for 30 days, and the performance, behavior, toxicity performance and death condition of the rats are observed every day.
1. After feeding for 30 days, fasting was performed for 10 hours, and blood was collected from abdominal aorta of rats, serum was separated, and Total Cholesterol (TCH), Triglyceride (TG) and blood sugar (GLU) contents of rats were measured using an enzymatic kit.
TABLE 4 measurement of Total Cholesterol (TCH), Triglyceride (TG) and blood sugar (GLU)
Total cholesterol (mmol-L) | Triglyceride (mmol/L) | Blood sugar (mmol/L) | |
Example 1 | 1.93 | 0.49 | 5.26 |
Example 2 | 1.66 | 0.41 | 4.92 |
Example 3 | 1.64 | 0.39 | 4.93 |
Example 4 | 1.43 | 0.31 | 4.37 |
Example 5 | 2.19 | 0.53 | 5.49 |
Example 6 | 2.23 | 0.54 | 5.53 |
Blank group | 3.72 | 0.68 | 6.41 |
2. Mouse peripheral blood immune cells and peritoneal macrophages: separately collecting eyeballs of mice in blank group and test group, collecting total peripheral blood (with mouse hemorrhagic shock as standard), and collecting with Tris-NH4After the CI solution hypotonically destroys the red blood cells, immune cells are counted, and then the mice after blood collection are dissected on a clean workbench, and abdominal cavity macrophages are taken for counting.
TABLE 5 blood immune cell and peritoneal macrophage assay results
From the results, the probiotic composition prepared by the invention has good effects of reducing blood sugar and blood fat, and also has good immune effect.
Claims (9)
1. The probiotic goat milk powder is characterized by comprising the following raw materials: goat milk, whey protein powder, peanut oil, walnut oil, plant nutrition powder, trehalose, L-carnitine, choline tartrate, compound vitamins, compound minerals, arachidonic acid, docosahexaenoic acid and a probiotic composition.
2. The probiotic goat milk powder as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight: 400 parts of goat milk, 30-60 parts of whey protein powder, 1-3 parts of peanut oil, 1-2 parts of walnut oil, 3-5 parts of plant nutrient powder, 0.3-0.5 part of trehalose, 0.05-0.08 part of L-carnitine, 0.03-0.05 part of choline tartrate, 0.1-0.2 part of vitamin complex, 0.1-0.2 part of compound mineral, 0.1-0.3 part of arachidonic acid, 0.1-0.2 part of docosahexaenoic acid and 1-2 parts of probiotic composition.
3. The probiotic goat milk powder as claimed in claim 1 or 2, wherein the vitamin complex is a mixture of L-ascorbic acid, retinol, cholecalciferol, folic acid, and D-calcium pantothenate in a mass ratio of 5 (1-2): 0.5-1): 0.3-0.5.
4. The probiotic goat milk powder as claimed in claim 1 or 2, wherein the compound mineral is a mixture of calcium chloride, ferrous sulfate, magnesium sulfate and sodium selenate in a mass ratio of 15 (1-5) to (1-3) to (0.05-0.1).
5. The probiotic goat milk powder as claimed in claim 1 or 2, wherein the plant nutrition powder is a mixture of burdock powder, cassia seed powder and tuckahoe powder in a mass ratio of (1-2): 3.
6. The probiotic goat milk powder of claim 1 or 2, wherein the probiotic composition consists of 20-60 wt% of bacillus natto lyophilized powder, 20-40 wt% of lactobacillus johnsonii lyophilized powder, and 20-40 wt% of akkermansia muciniphila lyophilized powder.
7. The probiotic goat milk powder of claim 6, wherein the Lactobacillus johnsonii lyophilized powder is prepared by the following method:
w1, strain activation: taking Lactobacillus johnsonii to streak on a solid culture medium B, and statically culturing for 30-48h at the constant temperature of 30-45 ℃ to obtain activated Lactobacillus johnsonii; the solid medium B was prepared as follows: uniformly mixing 1-5 wt% of peptone, 1-4 wt% of glucose, 0.1-1 wt% of magnesium sulfate, 1-5 wt% of agar powder and the balance of deionized water, and sterilizing at the temperature of 110-;
w2, expanding culture: inoculating activated Lactobacillus johnsonii in a liquid culture medium B, wherein the inoculation amount is 1-5 wt%, and culturing in a shaking table at 32-40 ℃ for 18-36h to obtain a seed solution B; the preparation method of the liquid culture medium B comprises the following steps: the beef extract is 10-20 wt%, the peptone is 10-30 wt%, the glucose is 20-40 wt%, the sodium acetate is 2-8 wt%, the citric acid diamine is 0.5-2 wt%, the dipotassium phosphate is 0.1-1 wt%, the Tween-800.1-1 wt%, the magnesium sulfate is 0.1-0.5 wt%, and the balance is deionized water, and the beef extract is uniformly mixed and sterilized at the temperature of 110-;
w3, fermentation: inoculating the seed liquid B into a fermentation medium B according to the inoculation amount of 2-6 wt%, and performing static fermentation at 30-45 ℃ for 8-18h to obtain a fermentation product B; the preparation method of the fermentation medium B comprises the following steps: the beef extract is 10-20 wt%, the peptone is 10-30 wt%, the glucose is 20-40 wt%, the sodium acetate is 2-8 wt%, the citric acid diamine is 0.5-2 wt%, the dipotassium phosphate is 0.1-1 wt%, the Tween-800.1-1 wt%, the magnesium sulfate is 0.1-0.5 wt%, and the balance is deionized water, and the beef extract is uniformly mixed and sterilized at the temperature of 110-;
w4, bacterial sludge collection and emulsification: centrifuging the fermentation product B at 10000-15000rpm for 10-30min, removing the supernatant, collecting bacterial sludge B, adding the bacterial sludge B into the freeze-drying protective agent B according to the mass ratio of 1 (1-4), and emulsifying at 150-200rpm for 10-30min to obtain an emulsion B; the preparation method of the freeze-drying protective agent B comprises the following steps: uniformly mixing 10-30 wt% of skimmed milk powder, 2-8 wt% of trehalose, 3-8 wt% of glycerol, 1-4 wt% of maltodextrin and the balance of deionized water;
w5, lyophilization and pulverization: freezing the emulsion B at-40 to-50 ℃ for 2-8h, drying at-50 to-70 ℃ under vacuum at 0.1 to 0.5mbar for 40-60h, taking out, pulverizing, and sieving with 10-40 mesh sieve to obtain Lactobacillus johnsonii lyophilized powder.
8. The probiotic goat milk powder of claim 6, wherein the preparation method of the akkermansia muciniphila freeze-dried powder is as follows:
x1, strain activation: taking Ackermanella muciniphila to streak on a solid culture medium C, and culturing for 20-28h at the constant temperature of 35-40 ℃ to obtain activated Ackermanella muciniphila; the solid medium C was prepared as follows: uniformly mixing 1-5 wt% of casein peptone, 0.5-2 wt% of glucose, 0.5-2 wt% of fucose, 0.1-1 wt% of threonine, 1-5 wt% of agar powder and the balance of deionized water, adjusting the pH to 6.0-7.0 by using 1-3mol/L hydrochloric acid solution, and sterilizing at the temperature of 110-;
x2, expanding culture: inoculating Ackermanella muciniphila in a liquid culture medium C with the inoculation amount of 1-4 wt%, and culturing in a shaker at 35-40 deg.C for 20-28h to obtain a seed solution C; the preparation method of the liquid culture medium C comprises the following steps: uniformly mixing 10-30 wt% of beef extract, 1-5 wt% of casein peptone, 0.5-2 wt% of glucose, 0.5-2 wt% of fucose, 0.1-0.5 wt% of threonine, 0.1-0.5 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH to 6.0-7.0 by using 1-3mol/L hydrochloric acid solution, and sterilizing at the temperature of 110-;
x3, fermentation: inoculating the seed liquid C into a fermentation culture medium C according to the inoculation amount of 2-8 wt%, and performing static fermentation at 35-40 ℃ for 12-24h to obtain a fermentation product C; the preparation method of the fermentation medium C comprises the following steps: uniformly mixing 10-30 wt% of beef extract, 1-5 wt% of casein peptone, 0.5-2 wt% of glucose, 0.5-2 wt% of fucose, 0.1-0.5 wt% of threonine, 0.1-0.5 wt% of magnesium sulfate and the balance of deionized water, adjusting the pH to 6.0-7.0 by using 1-3mol/L hydrochloric acid solution, and sterilizing at the temperature of 110-;
x4, bacterial sludge collection and emulsification: placing the fermentation product B obtained in the step X3 at 6000-10000rpm for centrifugation for 10-30min, removing the supernatant, collecting bacterial sludge C, adding the bacterial sludge C into the freeze-drying protective agent C according to the mass ratio of 1 (1-4), and emulsifying at 100-300rpm for 10-30min to obtain an emulsion C; the preparation method of the freeze-drying protective agent C comprises the following steps: uniformly mixing 10-30 wt% of skimmed milk powder, 2-8 wt% of glycerol, 3-10 wt% of oligomeric maltose and the balance of deionized water;
x5, lyophilization and pulverization: freezing the emulsion C at-40 to-50 ℃ for 2-8h, drying at-50 to-70 ℃ under a vacuum degree of 0.1 to 0.5mbar for 40-60h, taking out of the bin, crushing, and sieving with a 10-40 mesh sieve to obtain the adhesive protein akkermansia freeze-dried powder.
9. The method for preparing probiotic goat milk powder as claimed in any one of claims 1 to 8, comprising the steps of: adding whey protein powder, peanut oil, walnut oil, plant nutrient powder, trehalose, L-carnitine, choline tartrate, compound vitamins and compound minerals into goat milk, and uniformly mixing to obtain a mixed material I; preheating the mixed material I to 50-70 ℃, homogenizing at the homogenizing pressure of 200-220bar, heating to 90-100 ℃, and preserving the heat for 3-8s for sterilization to obtain a mixed material II; carrying out triple effect concentration on the mixed material II to 40-50% of the original weight to obtain a mixed material III; spray drying the mixture III, and cooling to room temperature to obtain a mixture IV; adding arachidonic acid, docosahexaenoic acid and a probiotic composition into the mixed material IV and uniformly mixing; and packaging, detecting and warehousing to obtain the product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110614503.8A CN113261592A (en) | 2021-06-02 | 2021-06-02 | Probiotics goat milk powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110614503.8A CN113261592A (en) | 2021-06-02 | 2021-06-02 | Probiotics goat milk powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113261592A true CN113261592A (en) | 2021-08-17 |
Family
ID=77233984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110614503.8A Withdrawn CN113261592A (en) | 2021-06-02 | 2021-06-02 | Probiotics goat milk powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113261592A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116622592A (en) * | 2023-07-21 | 2023-08-22 | 华南农业大学 | Application of buffalo milk in preparation of lactobacillus rhamnosus spray drying protective agent |
-
2021
- 2021-06-02 CN CN202110614503.8A patent/CN113261592A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116622592A (en) * | 2023-07-21 | 2023-08-22 | 华南农业大学 | Application of buffalo milk in preparation of lactobacillus rhamnosus spray drying protective agent |
CN116622592B (en) * | 2023-07-21 | 2023-10-20 | 华南农业大学 | Application of buffalo milk in preparation of lactobacillus rhamnosus spray drying protective agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102356816B (en) | Animal health care probiotics leavening capable of improving meat quality and application thereof | |
CN108208853A (en) | A kind of relieving alcoholism and protecting liver probiotics oligopeptide compound formulation and preparation method | |
CN107164274B (en) | Lactobacillus composite microbial agent and preparation method and application thereof | |
CN104381681A (en) | Antibiotic-free pig creep conservation general concentrate and complete feed thereof | |
CN113337435A (en) | Probiotic composition and application thereof in food | |
CN107047934A (en) | Using bacillus subtilis strain to strengthen the method for animal health | |
CN106222158B (en) | Preparation method of lactobacillus-embedding microcapsule | |
CN105685970A (en) | Compound nutritious food capable of improving whole digestive tract | |
CA3131258A1 (en) | Composition for preventing, improving or treating obesity or fatty liver disease comprising the leuconostoc citreum wikim0104 | |
CN109259146A (en) | One plant has effects that inhibit the Lactobacillus rhamnosus of fatty live lesions and its application | |
CN112244299A (en) | Probiotic composition with function of relieving non-alcoholic fatty liver and preparation method thereof | |
CN104509695A (en) | Preparation method for liquid feed additive | |
US20220160796A1 (en) | Composition for preventing, alleviating, or treating obesity or fatty liver disease, comprising weissella hellenica wikim0103 | |
CN105661230A (en) | Probiotic functional beverage and probiotic food prepared from Lens culinaris by fermentation | |
CN112075504A (en) | Infant formula milk powder for enhancing immunity | |
CN110200186B (en) | Probiotic solid beverage and preparation method thereof | |
CN102499290B (en) | Nutrient milk powder with selenium-enriched lentinus edodes and method for producing nutrient milk powder with selenium-enriched lentinus edodes | |
CN113261592A (en) | Probiotics goat milk powder and preparation method thereof | |
CN115053929B (en) | Formula milk powder suitable for fatty liver people and preparation thereof | |
CN113186118B (en) | Composite probiotic preparation for improving sow productivity and preparation method thereof | |
CN111406928B (en) | Red date fermented food with function of improving chronic diarrhea and preparation method and application thereof | |
US11246894B2 (en) | Superfood supplement for dogs and its manufacturing process | |
CN109567214B (en) | Health-care protein powder and preparation method and application thereof | |
JP2003047422A (en) | Lactic acid fermented food of whole soybean flour, bean- curd refuse and grifola frondosa, and method for producing the same | |
CN105994938A (en) | Production method of compound bacterium solid-state fermented maize protein meal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210817 |
|
WW01 | Invention patent application withdrawn after publication |